Cite

    Samjoo, I. et al. (2020). The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis. Current medical research and opinion. pp. 1145-1156. [Online].